This webinar will discuss the FDA requirements and guidelines for investigating Out-of-trend (OOT) results in the pharmaceutical laboratory. It will also cover FDA-compliant documentation of OOT, failure investigations, root causes, and CAPA.
FDA's guidance on OOS test results requires failure investigations and other steps for Out-of-Specification (OOS) and Out-of-trend (OOT) results. While most companies are familiar with and have procedures for OOS results, this is not the case for OOT situations. The guide states: "Although the subject of this document is OOS results, much of the guidance may be useful for examining results that are out of trend". Managing OOT results also helps to avoid time-consuming OOS results. The industry is unsure how to interpret and implement the FDA guidance.
This session will equip you with the knowledge and comprehensive understanding of FDA requirements for Out-of-Trend Results in pharmaceutical quality control.
FDA's guidance on OOS test results requires failure investigations and other steps for Out-of-Specification (OOS) and Out-of-trend (OOT) results. While most companies are familiar with and have procedures for OOS results, this is not the case for OOT situations. The guide states: "Although the subject of this document is OOS results, much of the guidance may be useful for examining results that are out of trend". Managing OOT results also helps to avoid time-consuming OOS results. The industry is unsure how to interpret and implement the FDA guidance.
This session will equip you with the knowledge and comprehensive understanding of FDA requirements for Out-of-Trend Results in pharmaceutical quality control.
Kelly Thomas
Ms. Thomas has over two decades of cGMP hands-on industry experience in both pharmaceutical and medical device manufacturing operations. Her experience covers all Quality Systems; as well as, all areas of validation; including, process/product validation, facilities validation, CSV and 21 CFR Part 11, test method validation, equipment/automated processes and cleaning validation.Utilizing strategic thinking, risk based approaches, and Lean principles, she has demonstrated success in steering and managing complex projects within the pharmaceutical and medical device industries.
Female to Female Hostility @Workplace: All you Need to Know
The Importance of the first 5 seconds when presenting
How to Manage the Legal Landmine of the FMLA, ADA and Worke…
Managing Difficult Employee Conversations
How to Write Effective Audit Observations: The Principles f…
Managing Toxic & Other Employees Who Have Attitude Issues
2025 EEOC & Employers: Investigating Claims of Harassment …
Leadership: Strategic Planning and Decision Making
FDA Proposes Framework to Advance Credibility of AI Models
Reduce Stress in the Workplace: Effective Ways to Handle Co…
ChatGPT and Project Management: Leveraging AI for Project M…
Leverage AI-Powered Tools for Talent Acquisition: Best Prac…
6-Hour Virtual Seminar on Learning the Highlights of Excel …
With Mandatory Paid Leave Gaining Ground Is It Time To Do A…
Form W-9 Compliance: TIN Verification, B Notices, and Avoid…
How to Give Corrective Feedback: The CARE Model - Eliminati…
Tattoos, hijabs, piercings, and pink hair: The challenges …
Stress, Change And Team Resilience Through Humor: An Intera…
Elevate Your Workplace Wellness: 10 Critical Wellness Facto…
AML Regulatory Insight for Q1 2025: Implementing recent cha…
How to Write Right for Better Business Communication
Gossip-Free: Leadership Techniques to Quell Office Chatter
Improving Employee Engagement & Retention Through Stay Inte…
Transforming Anger And Conflict Into Collaborative Problem …